As of June 30, 2026, Cosmo Chemical Co., Ltd. carries a market capitalization of 422.39B, placing it among publicly traded companies globally. Its enterprise value stands at 1.17T, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 422.39B |
| Enterprise Value | 1.17T |
As of June 30, 2026, Cosmo Chemical Co., Ltd. has 38.36M shares outstanding.
| Shares Outstanding | 38.36M |
These figures are as of June 30, 2026. The price-to-sales ratio is 0.59, and the price-to-book ratio stands at 1.80.
| PS Ratio | 0.59 |
| PB Ratio | 1.80 |
| P/TBV Ratio | 1.82 |
| P/FCF Ratio | 66.25 |
| P/OCF Ratio | 8.58 |
As of June 30, 2026, Cosmo Chemical Co., Ltd. trades at an EV/EBITDA multiple of 39.58 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.63 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 826.22 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 1.17T versus a market cap of 422.39B, with the gap driven by net debt and cash on the balance sheet.
| EV / Sales | 1.63 |
| EV / EBITDA | 39.58 |
| EV / EBIT | 826.22 |
As of June 30, 2026, Cosmo Chemical Co., Ltd. maintains a current ratio of 0.93, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 76.57, indicating elevated leverage, while an interest coverage ratio of 1.41 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.93 |
| Quick Ratio | 0.28 |
| Debt / Equity | 76.57 |
| Debt / EBITDA | 16.46 |
| Interest Coverage | 1.41 |
Over the twelve months ended June 30, 2026, Cosmo Chemical Co., Ltd. posted a negative return on equity (ROE) of -8.55, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -1.55, reflecting losses generated across the asset base. The company generates approximately 2.69B in revenue per employee across its workforce of 265.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 3.57 indicates how many times Cosmo Chemical Co., Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Equity (ROE) | -8.55 |
| Return on Assets (ROA) | -1.55 |
| Revenue Per Employee | 2.69B |
| Employee Count | 265.50 |
| Inventory Turnover | 3.57 |
Over the twelve months ended June 30, 2026, Cosmo Chemical Co., Ltd. recorded an income tax benefit of -1.24B rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -26.12B and -19.39B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.
| Income Tax | -1.24B |
As of the close on October 23, 2026, Cosmo Chemical Co., Ltd.'s stock has declined approximately 50.64% over the past 52 weeks. The 50-day moving average sits at 10,676.40, while the 200-day moving average is 13,205.30.
| 52-Week Price Change | -50.64% |
| 50-Day Moving Average | 10,676.40 |
| 200-Day Moving Average | 13,205.30 |
Over the twelve months ended June 30, 2026, Cosmo Chemical Co., Ltd. generated 715.14B in revenue and converted that into -19.39B in net income, yielding earnings per share of -648.47. EBITDA reached 29.49B, while operating income came in at 1.41B.
| Revenue | 715.14B |
| Gross Profit | 44.84B |
| Operating Income | 1.41B |
| Pretax Income | -26.12B |
| Net Income | -19.39B |
| EBITDA | 29.49B |
| EBIT | 1.41B |
| Earnings Per Share (EPS) | -648.47 |
As of June 30, 2026, Cosmo Chemical Co., Ltd. holds 139.59B in cash and equivalents against 485.27B in total debt, resulting in a net debt position of 353.30B. Total book value stands at 234.53B, with working capital of -36.19B providing operational flexibility.
| Cash & Cash Equivalents | 139.59B |
| Total Debt | 485.27B |
| Net Debt | 353.30B |
| Equity (Book Value) | 234.53B |
| Book Value Per Share | 6,113.18 |
| Working Capital | -36.19B |
Cosmo Chemical Co., Ltd. produced 49.22B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -42.84B in capital expenditures, free cash flow totaled 6.38B - equivalent to 166.18 per share.
| Operating Cash Flow | 49.22B |
| Capital Expenditures | -42.84B |
| Free Cash Flow | 6.38B |
| FCF Per Share | 166.18 |
Over the twelve months ended June 30, 2026, Cosmo Chemical Co., Ltd. posted a gross margin of 6.27, reflecting its pricing power and cost economics. The operating margin of 0.20 and net profit margin of -2.71 provide insight into operational efficiency.
| Gross Margin | 6.27 |
| Operating Margin | 0.20 |
| Pretax Margin | -3.65 |
| Profit Margin | -2.71 |
| EBITDA Margin | 4.12 |
These figures cover the twelve months ended June 30, 2026. Free cash flow yield stands at 1.51, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield is negative at -28.09, meaning Cosmo Chemical Co., Ltd. raised more capital through share issuance and new debt than it returned via dividends and buybacks.
| Shareholder Yield | -28.09 |
| FCF Yield | 1.51 |
Cosmo Chemical Co., Ltd.'s most recent stock split took place on September 5, 2023 with a 717:731 split ratio.
| Last Split Date | 9/5/2023 |
| Split Ratio | 717:731 |
As of June 30, 2026, Cosmo Chemical Co., Ltd. has an Altman Z-Score of 0.88, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 0.88 |
Already premium?